Author
Dirk Van Bockstaele
Also Known As
D Van Bockstaele, D van Bockstaele, D. VAN BOCKSTAELE, D. Van Bockstaele, D. Van Bockstaele†, D. van Bockstaele, Dirk Bockstaele, Dirk Van Bockstaele, Dirk van Bockstaele, Wolfgang R. Sperr
55
Publications
2.1K
Citations
22
H-Index
113
Concepts
All Affiliations
| # | Concept | H-Index | Publications | Citations |
|---|---|---|---|---|
1 | Medicine | 18 | 22 | 1.4K |
2 | Natural Sciences | 9 | 9 | 643 |
3 | Health Sciences | 3 | 3 | 166 |
4 | Public Health | 3 | 3 | 145 |
5 | Engineering | 2 | 2 | 71 |
Dirk Van Bockstaele
×
27
Publications
1.8K
Citations
20
H-Index
| Year | Citations | |
|---|---|---|
2001 | 340 | |
1999 | 233 | |
2002 | 184 | |
2006 | 155 | |
2009 | 84 | |
1998 | 81 | |
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML) Harry P. Erba, Hamid Sayar, Mark Juckett, Hematological MalignancyOncologyMedicineAcute Myeloid LeukemiaMixed-phenotype Acute Leukemia | 2013 | 71 |
2006 | 67 | |
1999 | 60 | |
2002 | 58 |
Page 1
Page 1